Laird Norton Trust Company, LLC Clene Inc. Transaction History
Laird Norton Trust Company, LLC
- $738 Million
- Q1 2024
A detailed history of Laird Norton Trust Company, LLC transactions in Clene Inc. stock. As of the latest transaction made, Laird Norton Trust Company, LLC holds 268,581 shares of CLNN stock, worth $88,631. This represents 0.02% of its overall portfolio holdings.
Number of Shares
268,581
Previous 268,581
-0.0%
Holding current value
$88,631
Previous $80,000
43.75%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CLNN
# of Institutions
54Shares Held
7.44MCall Options Held
48.1KPut Options Held
160K-
Vanguard Group Inc Valley Forge, PA2.62MShares$864,5010.0% of portfolio
-
Geode Capital Management, LLC Boston, MA947KShares$312,3550.0% of portfolio
-
Lunt Capital Management, Inc. Holladay, UT513KShares$169,2440.11% of portfolio
-
Scoggin Management LP New York, NY500KShares$165,0000.08% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL474KShares$156,4620.0% of portfolio
About Clene Inc.
- Ticker CLNN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,502,000
- Market Cap $21M
- Description
- Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...